NFKB1 and early-onset autosomal dominant Alzheimer disease: Improving memory and learning abilities in animal experiments (in humans, data are inconsistent). Protection against inflammation induced by beta-amyloid in Alzheimer’s disease, suppression of the expression of NF-kB and Toll-like receptor, increased energy of brain tissue mitochondria